ema bpc-157 approval BPC-157: Experimental Peptide Creates Risk for Athletes Peptide Therapy in Maine |

Their expertise ensures that each patient receives a personalized treatment plan for optimal results

The research, published in the Journal of Endocrinology and Metabolism, found that the peptide had no effect on serum IGF-1 levels, no negative effect on carbohydrate metabolism, and no anti-AOD-9604 antibodies were detected in any patients

Thereafter, the practical applicability was supported by the per oral application of the therapy given continuously in drinking water until the end of the one-month period

Compounded in Thailand Manufactured in Thai FDA-licensed compounding laboratories operating under GMP standards